reviewNature reviews. CancerOct 24, 2011Closed access

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

The University of Texas MD Anderson Cancer Center · Memorial Sloan Kettering Cancer Center · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

637
total citations
FWCI
22.00
Percentile
100%
References
65
Citations per year

Authors

4

Topics & keywords

Keywords
  • Ipilimumab
  • Medicine
  • Immunotherapy
  • Food and drug administration
  • Prostate cancer
  • Clinical trial
  • Cancer
  • Melanoma
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding